The objective of this study was to elucidate the role of calcium (Ca ++ ) signalling in the chondrogenic response of mesenchymal stem cells (MSCs) to hydrostatic pressure (HP). MSCs were seeded into agarose hydrogels, subjected to HP or kept in free swelling conditions, and cultured either with or without pharmacological inhibitors of Ca ++ mobility and downstream targets. Chelating free Ca ++ , inhibiting voltage-gated calcium channels, and depleting intracellular calcium stores suppressed the beneficial effect of HP on chondrogenesis, indicating that Ca ++ mobility may play an important role in the mechanotransduction of HP. However, inhibition of stretch-activated calcium channels in the current experiment yielded similar results to the control group, suggesting that mechanotransduction of HP is distinct from loads that generate cell deformations. Inhibition of the downstream targets calmodulin, calmodulin kinase II, and calcineurin all knocked down the effect of HP on chondrogenesis, implicating these targets in MSCs response to HP. All of the pharmacological inhibitors that abolished the chondrogenic response to HP also maintained a punctate vimentin organisation in the presence of HP, as opposed to the mechanoresponsive groups where the vimentin structure became more diffuse. These results suggest that Ca ++ signalling may transduce HP via vimentin adaptation to loading.
Introduction
Mechanical cues play a key role in mesenchymal stem cell (MSC) differentiation (Discher et al., 2009; Kelly and Jacobs, 2010; McBeath et al., 2004; Steward et al., 2011; Thorpe et al., 2012) . The response to such cues strongly depends on the type (i.e. compression, fluid flow, tension, hydrostatic pressure), frequency, magnitude, and duration of loading (Kelly and Jacobs, 2010; Meyer et al., 2011; Miyanishi et al., 2006b; Steward et al., 2013b) . Fluid pressurisation is the dominant load-bearing mechanism of cartilage, supporting up to 90 % of the compressive load in the in vivo joint environment (Park et al., 2003) . In accordance with its prominence in cartilaginous tissues, hydrostatic pressure (HP) is an important regulator of chondrogenic differentiation of MSCs, increasing chondrogenic gene expression and matrix production, and also suppressing markers of hypertrophy (Angele et al., 2003; Carroll et al., 2014; Luo and Seedhom, 2007; Meyer et al., 2011; Miyanishi et al., 2006a; Miyanishi et al., 2006b; Ogawa et al., 2009; Steward et al., 2012; Steward et al., 2013a; Vinardell et al., 2012; Wagner et al., 2008; Wong et al., 2003) . Mechanotransduction of HP has been proposed to differ from other mechanical loads due to the fact that HP generates a state of stress with little deformation (Elder and Athanasiou, 2009) , as hydrated tissues and cells are nearly incompressible. However, surprisingly little is known about the mechanisms by which cells sense and respond to HP.
Recently, we demonstrated that integrin binding to the pericellular matrix regulates vimentin organisation in MSCs and determines their response to cyclic HP (Steward et al., 2013a) . Another proposed element of HP mechanotransduction is fluctuations in intracellular ion concentrations, which are altered by the application of HP (Browning et al., 2004; Hall, 1999; Mizuno, 2005) . In particular, calcium ion (Ca ++ ) signalling has been implicated as a critical regulator of cellular response in other mechanical loading modalities, yet no studies have examined the role of Ca ++ signalling in the response of MSCs to HP. Ca ++ signalling is complex and involves a variety of channels, receptors and secondary messengers (Fig. 1) . Stretch activated calcium channels (SACCs) have been demonstrated to be required for mechanotransduction of a variety of loading types in chondrocytes and MSCs (McMahon et al., 2008; Mizuno, 2005; Mobasheri et al., 2002; Wright et al., 1996) . Voltage gated calcium channels (VGCCs) are activated by membrane depolarisation and AJ Steward et al. MSC mechanotransduction of HP via Ca ++ signalling mediate Ca ++ influx (Catterall, 2011) . Ca ++ influx via SACCs and/or VGCCs increases Ca ++ concentrations directly and also indirectly through calcium-induced calcium release via calcium-sensitive receptors in the sarcoendoplasmic reticulum calcium stores (SERCS) (Catterall, 2011) . VGCCs and SERCS were both found to be required for chondrogenesis in high-density chicken MSCs culture (Fodor et al., 2013) , and they have both been implicated in mechanotransductive pathways (Riddle et al., 2006; Shakibaei and Mobasheri, 2003; Valhmu and Raia, 2002) . Finally, Ca ++ utilises secondary messengers, such as calmodulin (CaM), calmodulin kinase type II (CaMKII) and calcineurin (Cn), which subsequently initiate a variety of signalling cascades. CaM, CaMKII and Cn have been implicated in mechanotransduction of fluid flow and compression in MSCs as well as chondrocytes (Riddle et al., 2006; Valhmu and Raia, 2002) .
While intracellular Ca ++ concentrations are known to increase in chondrogenic cells after application of HP (Mizuno, 2005) , the effects of this increase on the chondrogenesis of MSCs and the specific channels and downstream effectors utilised by MSCs to sense and respond to HP are unknown. Further, integrins, the cytoskeleton, and Ca ++ channels have previously been proposed to interact with one another (Erickson et al., 2003; Mobasheri et al., 2002; Shakibaei and Mobasheri, 2003; Wright et al., 1997) , thus recent findings that integrin binding and cytoskeletal organisation regulate the mechanotransduction of HP implicate a possible role for Ca ++ signalling in mediating this process. Therefore, in order to elucidate the role of Ca ++ signalling in the mechanotransduction of HP, chondrogenic matrix accumulation, focal adhesion formation and cytoskeletal organisation were examined in MSCs exposed to HP in the presence of pharmacological inhibitors of Ca ++ mobility and downstream signalling molecules.
Materials and Methods
Cell isolation, expansion and encapsulation Femora from 6-month-old pigs (~ 50 kg) were procured from a local abattoir (Martin's Custom Butchering, Wakarusa, IN, USA) and the bone marrow was harvested from the diaphysis within 3 h of slaughter under sterile conditions. MSCs were isolated and expanded according to a modified method developed for human MSCs (Lennon and Caplan, 2006) . Briefly, bone marrow was removed from the femur, washed and centrifuged twice, and sieved through a 40 μm pore-size cell sieve (Falcon, VWR, Batavia, IL, USA). The remaining cell suspension was counted by trypan blue exclusion and seeded at a density of 80 x 10 6 cells per 75 cm 2 T-flask in a humidified atmosphere of 37 °C and 5 % CO 2 . Non-adherent cells were removed after 3 d in culture. At each passage, cells were reseeded at a density of 875,000 cells per 175 cm 2 T-flask. Cultures were expanded in high-glucose Dulbecco's modified Eagle's Medium (hgDMEM GlutaMAX; Gibco, Life Technologies, Grand Island, NY, USA) supplemented with 10 % foetal bovine serum (FBS; Omega Scientific, Tarzana, CA, USA), and penicillin (100 U/mL)-streptomycin (100 μg/ mL) (Corning, VWR). After expansion (third passage) MSCs were encapsulated in agarose (Type VII, SigmaAldrich, St. Louis, MO, USA) at a density of 15 x 10 6 cells/mL. Briefly, MSCs were mixed with 5 % agarose AJ Steward et al. MSC mechanotransduction of HP via Ca ++ signalling at ~ 40 °C to yield a final gel concentration of 4 %. The agarose-cell suspension was cast in a stainless steel mould, and cored using biopsy punches to produce cylindrical scaffolds (Ø 5 x 3 mm thickness). Constructs were maintained in 2.5 mL/construct of a chemically defined medium consisting of hgDMEM GlutaMAX supplemented with penicillin (100 U/mL)-streptomycin (100 μg/mL), 100 μg/mL sodium pyruvate (Lonza, VWR), 40 μg/mL L-proline (Sigma-Aldrich), 50 μg/mL L-ascorbic acid-2-phosphate (Sigma-Aldrich), 1.5 mg/mL bovine serum albumin (BSA, Fisher Scientific, Pittsburgh, PA, USA), 1 x insulin-transferrin-selenium (Gibco, Life Technologies), 100 nM dexamethasone (Sigma-Aldrich) and 10 ng/ mL recombinant human transforming growth factor-β3 (TGF-β3; PeproTech, Rocky Hill, NJ, USA). In order to inhibit Ca ++ mobility, constructs were incubated with either 5 μM BAPTA-AM (an intracellular calcium chelator, -Ca ++ ; Valhmu and Raia, 2002) , 10 μM GdCl 3 (inhibits stretchactivated calcium channels, -SACC; McMahon et al., 2008) , 10 μM verapamil (inhibits voltage-gated calcium channels, -VGCC; Hung et al., 1996a) , 50 nM thapsigargin (depletes sarco/endoplasmic reticulum calcium stores, -SERCS; Yellowley et al., 1997) (all Sigma-Aldrich), or without any pharmacological inhibitors as a control (Ctrl). In a second experiment, the role of downstream targets of Ca ++ signalling was investigated with either 5 μM W-7 (inhibits calmodulin, -CaM; Xu et al., 2009) , 10 μM KN-62 (inhibits calmodulin kinase type II, -CaMKII; Szabo et al., 2009) , or 3.5 μM cyclosporine A (inhibits calcineurin, -Cn; Tomita et al., 2002 ) (all Sigma-Aldrich). Constructs were allowed to equilibrate overnight before the initiation of hydrostatic pressure. The constructs were cultured with the relevant pharmacological inhibitor (or without inhibitors in the control groups) for the duration of the experiment.
Application of hydrostatic pressure
Constructs (n = 9) were sealed into sterile bags with 1.5 mL of medium per construct during the daily loading period. After loading, constructs were removed from bags and returned to culture dishes containing 2.5 mL of medium per construct to allow gases to equilibrate overnight. Cyclic HP was applied in a cell disruption bomb (Parr Instrument Company, Moline, IL, USA) filled with water within a 37 °C water bath as described previously (Meyer et al., 2011) . The sealed bags exposed to HP were placed into the pressure vessel while the free swelling (FS) controls were placed in a separate pressure vessel, which was immersed in the same temperature-regulated water bath but was not connected to the mechanical testing system. The pressure vessel was connected to a hydraulic cylinder (PHD, Inc., Fort Wayne, IN, USA) that was loaded using a computer controlled Instron 88215 materials testing machine. The pressure inside the vessel was measured using a pressure gauge (McMaster-Carr, Princeton, NJ, USA). The load applied to the hydraulic cylinder by the Instron was such that the HP inside the vessel reached an amplitude of 10 MPa at a frequency of 1 Hz, 4 h/d, 5 d/week for 3 weeks. Half-medium exchanges were performed every 3-4 d to replenish nutrients and pharmacological inhibitors, and media samples were collected for biochemical analysis on day 21.
Biochemical analysis
On day 21 constructs (n = 4) were digested with papain (125 μg/mL) in 0.1 M sodium acetate, 5 mM L-cysteineHCl, and 0.05 M EDTA (pH 6.0, all Sigma-Aldrich) at 60 °C under constant rotation for 18 h. The PicoGreen assay (Life Technologies) was used to quantify DNA content. Sulphated glycosaminoglycan (sGAG) content was quantified using a modified dimethylmethylene blue (DMMB) dye-binding assay with a chondroitin sulphate standard. Briefly, aliquots of the papain digest were mixed with a dye solution consisting of 80 µM DMMB (SigmaAldrich), 1 % ethanol (Acros Organics, VWR), 40 mM guanidine-HCl (Calbiochem, VWR), 315 µM formic acid, and 25 µM sodium hydroxide (Sigma-Aldrich) at a pH of 3.5 for 30 min and then centrifuged. The supernatant was removed and the remaining pellet was resuspended in a Fig. 2 . A custom MATLAB code converted raw confocal images of vimentin structure to images of pixel intensity and subsequently averaged over a 2 x 2 grid of pixels to smooth the image. Finally, a distribution of intensities within each cell was plotted and the standard deviation was used as a measure of homogeneity within each cell.
AJ Steward et al. MSC mechanotransduction of HP via Ca ++ signalling dissociation buffer of 10 % isopropanol (Alfa Aesar, VWR) and 4 M guanidine-HCl (Calbiochem, VWR). The resultant solution was measured colourimetrically at 600 nm. Media samples were also analysed for sGAG content using the modified DMMB assay, and subsequently added to that accumulated within constructs to yield the total sGAG produced. Total sGAG/DNA values from the HP groups were normalised to the FS groups when applicable. All assays were performed in triplicate.
Confocal microscopy and immunohistochemistry
At day 21, constructs (n = 2) were cut in half and fixed in 4 % paraformaldehyde (Fisher Scientific) overnight at 4 °C and rinsed with phosphate-buffered saline (PBS). In order to examine focal adhesion formation and cytoskeletal organisation, samples were permeabilised in a 1 % Triton-X and 2 % BSA solution for 45 min and washed in PBS. The samples were then incubated in a 1.5 % BSA solution containing one of either 60 μg/mL monoclonal anti-vinculin FITC conjugate (Sigma-Aldrich), 5 U/mL rhodamine phalloidin (VWR), 1 μg/mL anti-vimentin FITC (eBioscience, Inc., San Diego, CA, USA), or 1 μg/ mL anti-alpha tubulin eFluor ® 615 (eBioscience, Inc.) for 1.5 h, and then imaged using a Nikon A1R confocal microscope at 40 x magnification.
A custom code (MATLAB R2013a, The Mathworks, Inc., Natick, MA, USA) was developed in order to analyse the confocal images semi-quantitatively (Fig. 2) . All cells in the plane of view of at least five representative images were selected in MATLAB and converted to an image of pixel intensity. Then, the intensities of 2 x 2 pixel squares (0.6 x 0.6 µm) were averaged in order to smooth the (HP normalised to FS) AJ Steward et al. MSC mechanotransduction of HP via Ca ++ signalling image. Next, all non-zero intensity values were compiled and the intensity of each square was normalised to the mean intensity of the given image. Finally, the standard deviation of the intensities was found as a measure of the homogeneity of the cytoskeletal architecture. These standard deviations were then averaged across multiple cells from each group (27 ≤ n ≤ 48). Finally, the number of cells that had punctate or diffuse vimentin architecture was visually determined in the control HP and FS groups. The remaining halves were dehydrated and embedded in paraffin wax. Constructs were sectioned perpendicular to the disc face yielding 5 μm thick sections. Collagen type II was then identified through immunohistochemistry.
Sections were treated with peroxidase, followed by chondroitinase ABC (Sigma-Aldrich) in a humidified environment at 37 °C for 1 h to permeabilise the extracellular matrix. Samples were then blocked with goat serum, and afterwards the primary antibody for collagen type II (mouse monoclonal, Abcam, Cambridge, MA, USA) was applied for 1 h. Next, the secondary antibody (anti-mouse IgG biotin conjugate, Sigma-Aldrich) was added for 1 h followed by incubation with ABC reagent (Thermo Scientific, VWR) for 45 min. Finally, the slides were developed with DAB peroxidase (Thermo Scientific, VWR) for 5 min. Samples were washed with PBS between each step. 
Statistical analysis
Statistical analysis was performed using Prism (version 4.03, GraphPad Software, La Jolla, CA, USA). Biochemical results, both numerical and graphical, are expressed in the form of mean ± standard deviation. Differences between HP and FS samples were determined using a Student's t-test, while differences between groups cultured with or without the various inhibitors tested were determined using a one-way ANOVA with Bonferroni post-test. A level of p < 0.05 was considered significant.
Results

Ca
++ mobility may be a key regulator of the mechanotransduction of HP Previous work has demonstrated that porcine bone marrow-derived MSCs remain viable in agarose hydrogels for up to 42 d (Thorpe et al., 2008; Thorpe et al., 2010) , and we have observed 90 % DNA content on day 21 as compared to day 0, on average, during several of our previous experiments (data not shown). Additionally, we have previously reported that HP does not alter the DNA quantity of MSC-seeded agarose constructs after 21 d of loading . To determine whether the DNA content is altered by the presence of pharmacological inhibition of Ca ++ mobility, DNA in the free-swelling Ctrl, -Ca ++ , -SACC, -VGCC and -SERCS constructs from the first experiment was quantified at day 21. None of the inhibitors had a significant effect on the DNA levels (Fig.  3a) . Additionally, the quantity of sGAG/DNA was also not significantly different between the different groups (Fig.  3b) , suggesting that chondrogenic differentiation was not altered by the addition of the inhibitors.
In the control specimens, HP significantly enhanced sGAG synthesis by 23 % (Fig. 4a) , and also increased collagen type II immunostaining (Fig. 4b) . Interestingly, inhibition of Ca ++ signalling with an intracellular calcium chelator (-Ca ++ ) suppressed the beneficial effect of HP on sGAG production and collagen type II accumulation (Fig.  4a,b) . Next, SACCs, VGCCs and SERCS were suppressed in order to determine how Ca ++ signalling was being initiated by HP. Hindering SACC activity did not negate the beneficial effects of HP on sGAG accumulation or collagen type II deposition; however, inhibition of both VGCCs and SERCS abrogated the mechanoresponse of MSCs to HP (Fig. 4a,b) . (FS normalised to HP)
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Ca ++ mobility may be required for changes in vimentin architecture in response to HP Focal adhesion formation was previously determined to be necessary for mechanotransduction of HP (Steward et al., 2013a) . Therefore, focal adhesions were next examined with confocal microscopy in order to determine if inhibition of Ca ++ mobility was regulating the mechanoresponse of MSCs to HP via alterations in focal adhesion formation.
Neither the pharmacological inhibitors nor application of HP affected focal adhesion formation, with all groups demonstrating a punctate structure (Fig. 5) .
The cytoskeleton has long been implicated in mechanotransduction, yet no changes were observed in actin or tubulin structure with either inhibition of Ca ++ mobility or application of HP (Fig. 5) . However, exposure to HP led to a more diffuse vimentin structure in the 
mechanosensitive groups (Control and -SACCs), while retaining a punctate structure in the other groups (Fig.  6a) . Semi-quantitative analysis of vimentin architecture verified this observation, as there was only a significant difference in vimentin architecture with loading in the mechanosensitive groups (Fig. 6b) . A 15 % decrease in the number of punctate cells was observed after exposure to HP in the control group.
CaM, CaMKII and Cn may all regulate the mechanotransduction of HP
In the second experiment, DNA and sGAG/DNA values were also assessed in free-swelling constructs exposed to inhibitors of the downstream calcium targets CaM, CaMKII and Cn. While inhibiting CaMKII led to a significant increase in DNA, none of the inhibitors had a significant effect on the chondrogenic state of the MSCs (Fig. 7) . Inhibition of CaM, CaMKII and Cn all led to a suppression of the beneficial effect of HP on sGAG accumulation (Fig. 8a) . Similar to the first experiment, collagen type II accumulation was increased in the control group, but inhibition of CaM, CaMKII and Cn abrogated this response (Fig. 8b) .
CaM, CaMKII and Cn may be required for changes in vimentin architecture in response to HP No changes in focal adhesion formation or tubulin architecture were observed with application of either HP or downstream calcium target inhibitors, with all groups retaining punctate focal adhesion formations and diffuse tubulin staining. However, all three inhibitors led to a punctate actin structure that was not affected by application of HP (Fig. 9) . As above, MSCs demonstrated a punctate vimentin structure that became more diffuse in response to loading in the control group. However, inhibition of CaM, CaMKII and Cn all abrogated the effect of HP on vimentin (FS normalised to HP) AJ Steward et al. MSC mechanotransduction of HP via Ca ++ signalling architecture (Fig. 10a) . Semi-quantitative analysis of the vimentin structure further verified that inhibition of CaM, CaMKII and Cn block the change in vimentin structure in response to HP (Fig. 10b) .
Discussion
Similar to previous studies examining other loading modalities such as tension, compression, fluid flow, and osmotic pressure Chao et al., 2006; Guilak et al., 1999; McMahon et al., 2008; Mobasheri et al., 2002; Pingguan-Murphy et al., 2006; Riddle et al., 2006; Roberts et al., 2001; Valhmu and Raia, 2002; Yellowley et al., 1997) , Ca ++ signalling appeared to be necessary for the mechanotransduction of HP in MSCs. This was evidenced by the lack of a response to the mechanical load when intracellular calcium was chelated (-Ca ++ ). Mechanotransduction of HP has been proposed to differ from other mechanical loads due to the fact that HP generates a state of stress with little deformation (Elder and Athanasiou, 2009) , and indeed this was observed in the mechanism by which Ca ++ signalling was initiated. Stretchactivated calcium channels (SACCs) play a key role in the mechanoresponse of MSCs to tension, compression, and fluid flow (McMahon et al., 2008; Mobasheri et al., 2002; Roberts et al., 2001; Yellowley et al., 1997 ); yet, in the current study, their inhibition did not suppress the mechanoresponse of the MSCs to cyclic HP. These results suggest that the mechanotransductive pathways utilised by MSCs in response to HP are distinct from those used to sense and respond to other loading modalities.
Although inhibition of SACCs did not alter the mechanoresponse of MSCs to cyclic HP in the current study, calcium flux through these channels has been observed in response to static HP loading. Mizuno (2005) utilised X-rhod-1 AM and a live-cell imaging bioreactor to measure Ca ++ concentrations in chondrocytes exposed to 0.5 MPa static HP. Blocking SACCs decreased Ca ++ mobility and inhibition of VGCCs had no effect on Ca ++ mobility in response to this static load. In a separate study, cyclic HP had been shown to increase proteoglycan synthesis, while static HP had no effect (Jortikka et al., 2000) . Therefore, the differences between Mizuno's observations and those of the current study may be explained by a differential response of MSCs to static versus cyclic HP. Similarly, inhibition of SACCs blocked Ca ++ mobility and early osteogenic markers in response to static fluid flow (Chen et al., 2000; Hung et al., 1996b; Yellowley et al., 1997) ; however, inhibition of SACCs did not affect Ca ++ mobility or osteopontin gene expression in response to oscillatory fluid flow (You et al., 2001) . Together, these data suggest that in some cases, SACCs may be more sensitive to static stimuli than oscillatory ones.
In the current study, inhibition of VGCCs and SERCS both appeared to inhibit the chondrogenic response of MSCs to HP. These results suggest that Ca ++ could potentially enter through VGCCs and subsequently activate calcium-induced calcium release from SERCS. Both VGCCs and SERCS have been shown to be involved in the mechanotransduction of extrinsic mechanical loads, such as fluid flow and compression (Riddle et al., 2006; Shakibaei and Mobasheri, 2003; Valhmu and Raia, 2002) . Therefore, although the mechanotransductive pathways involved in the response to HP are distinct from other loading modalities, there appear to be some overlapping principles. Compression of cartilage in the joint pressurises the fluid phase of cartilage and generates HP. Therefore, the fact that studies utilising compression and HP appear to have overlapping mechanotransductive principles could be due to the fact that compressive loading generates a state of HP as well.
Once Ca ++ enters the cell, secondary messengers are commonly utilised to translate the signal into changes in gene expression. Ca ++ binds to CaM, inducing a conformational change that allows it to bind to CaMKII and Cn. CaM, CaMKII and Cn are all proposed to regulate the mechanotransduction of extrinsic loads (Valhmu and Raia, 2002) . Compressive loading of bovine articular cartilage explants led to a 2-4 fold increase in aggrecan expression that was abrogated with the additions of inhibitors of CaM, CaMKII and Cn (Valhmu and Raia, 2002) . Similarly, in the current study, inhibition of CaM, CaMKII and Cn all appeared to suppress the beneficial effects of HP on the chondrogenesis of MSCs. Together, this indicates that Ca ++ / CaM binding, and its subsequent interaction with CaMKII and Cn, may be an important mechanotransductive pathway in chondrogenic cells.
Cell-matrix interactions regulate chondrogenesis , and previously, we have demonstrated that integrin binding is required for the mechanotransduction of HP (Steward et al., 2013a) . Integrin binding has been correlated with Ca ++ signalling in response to several mechanical stimuli (Matthews et al., 2006; Mobasheri et al., 2002; Shakibaei and Mobasheri, 2003; Wright et al., 1997; Wu et al., 1998) . Integrins have been found to co-localise with VGCCs , and inhibition of integrin binding has been found to decrease Ca ++ mobility (Wright et al., 1997; Wu et al., 1998) . Vinculin staining was not altered with either the application of HP or pharmacological inhibitors, suggesting that any differences observed in response to loading were not due to alterations in integrin binding or focal adhesion formation following the application of such stimuli. The cytoskeleton has been demonstrated to be involved in the mechanotransduction of many different mechanical stimuli and has also been associated with Ca ++ signalling (Arnsdorf et al., 2009; Chen et al., 2000; Erickson et al., 2003; Formigli et al., 2007; Sadoshima et al., 1992) . None of the inhibitors of Ca ++ mobility affected actin, vimentin, or tubulin organisation; however, the inhibitors of CaM, CaMKII and Cn all led to a more punctate actin structure. While this could potentially alter the mechanoresponse of the MSCs to HP, a previous study indicated that complete disruption of the actin structure did not influence the mechanotransduction of HP (Shim et al., 2008) . Therefore, it seems unlikely that the alterations in actin structure observed in the presence of inhibitors of CaM, CaMKII and Cn influenced the chondrogenic response of MSCs to HP.
Previously, we demonstrated a novel role for vimentin in the chondrogenic response of MSCs to HP, as vimentin AJ Steward et al. MSC mechanotransduction of HP via Ca ++ signalling staining transitioned from a punctate appearance in freeswelling conditions to a more diffuse organisation when exposed to HP in a percentage of the cells (Steward et al., 2013a) . In the current experiment, vimentin organisation was more likely to be punctate in all of the free-swelling conditions, including in the controls and in the specimens exposed to the pharmacological inhibitors. Similar to the previous experiment, vimentin staining became more diffuse when the MSCs were exposed to HP in the mechanoresponsive groups (Ctrl and -SACCs). However, vimentin remained more punctate with loading in the -Ca ++ , -VGCCs, -SERCS, -CaM, -CaMKII and -Cn groups. Overall, this might suggest that Ca ++ mobility and associated targets act upstream of changes to vimentin structure. On the other hand, inhibition of Ca ++ signalling may abrogate the chondrogenic mechanoresponse to HP via a different mechanism that in turn affects the vimentin structure. Overall, this suggests that vimentin reorganisation is integrally correlated to the chondrogenic response of MSCs to HP, and that this reorganisation may be calcium-dependent.
Based on a visual determination of the number of loaded and unloaded cells that had punctate or diffuse vimentin organisation, approximately 15 % of control cells (cells not exposed to any inhibitors) responded to the application of HP with cytoskeletal reorganisation. As vimentin reorganisation was only observed in the mechanoresponsive groups, this 15 % of cells may represent a mechanosensitive subpopulation of the heterogeneous MSCs. Chondrocytes have also been observed to have subpopulations of mechanosensitive cells, as previous studies found that, on average, 20-60 % of chondrocytes embedded in agarose expressed Ca ++ transients in response to dynamic compression (Pingguan-Murphy et al., 2005; Roberts et al., 2001) . Additionally, previous experiments comparing DNA values after 3 weeks to their initial day 0 values suggested an average loss of 10 % of cell number during the culture period; the actual number of cells that did not survive may be greater, as some could have been replaced by proliferating cells. By comparing the number of potentially mechanosensitive cells with the number of cells that do not survive culture, we cannot rule out the possibility that the pharmacological inhibitors used in the current study selected against the mechanoresponsive cells while allowing other cells to survive or proliferate, rather than inhibiting calcium signalling. If this were the case, Ca ++ inhibitors would not be an appropriate tool to determine the mechanotransduction pathways of chondrogenic MSCs in agarose. In order to be certain of the effect of the inhibitors on the heterogeneous MSC population, a flow cytometry analysis would be required to determine whether a particular phenotype had a lower viability in the presence of inhibitors. However, the markers that would represent mechanoresponsive cells are currently unknown. Furthermore, the possibility that the inhibitors used in the current study would all target the same mechanoresponsive cell population without significantly altering the final DNA and sGAG concentrations in the FS constructs seems unlikely due to the number and variety of inhibitors that eliminated the chondrogenic response to HP. Although an in-depth analysis of the sub-populations of MSCs could yield important findings on the characteristics of mechanoresponsive MSCs, the lack of a consensus in the field on the specific markers of interest limits the utility of this approach.
While VGCCs seem to be critical for a chondrogenic response to HP, the mechanism triggering these channels is unclear. One possibility is that purinergic signalling is acting to trigger the VGCCs. In the purinergic mechanotransduction pathway, MSCs release ATP in response to mechanical loading, and this extracellular ATP in turn induces P-receptors to increase the intracellular Ca ++ concentration by either direct or indirect methods. The increased intracellular Ca ++ depolarises the membrane, leading to activation of VGCCs (Bodin and Burnstock, 2001; Pingguan-Murphy and Knight, 2008) . Purinergic signalling has been implicated in the mechanotransduction of fluid flow and compression (Graff et al., 2000; PingguanMurphy et al., 2006) , yet no studies have investigated its potential role in the mechanotransduction of HP. Alternatively, HP has been shown to inhibit the Na/K pump, Na/K/2Cl pump, and enhance the Na/H pump (Browning et al., 1999; Elder and Athanasiou, 2009; Hall, 1999) . By altering the concentrations of these other ions, VGCCs could potentially be activated. Finally, although HP generates a state of little deformation, it has been proposed that ion channels may contain compressible void spaces that, when exposed to HP, may lead to conformational changes in these proteins and subsequently alter ion mobility (Elder and Athanasiou, 2009; Kornblatt and Kornblatt, 2002) .
Overall, we have demonstrated that Ca ++ signalling may play a critical role in the chondrogenic response of MSCs exposed to HP. The signalling pathway utilised by MSCs appears to involve VGCCs, SERCS, CaM, CaMKII and Cn. SACCs do not appear to play a role in the mechanotransduction of HP, suggesting that the mechanotransductive pathways utilised in response to cyclic HP are distinct from other loading modalities. Vimentin reorganisation in response to HP appears to be Ca ++ signalling dependent and possibly plays a key role in the chondrogenic response of MSCs to HP. Finally, further research is needed to fully understand the mechanisms by which HP alters Ca ++ mobility.
